Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T21:14:25.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T20:13:39.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added. The prior funding-status notice was removed; no changes were made to core study information.
    Difference
    0.4%
    Check dated 2026-02-11T02:06:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a site-wide government funding and operation status notice and updated the page revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:57:28.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    UI/metadata updates were introduced: a glossary display option is now shown, and the QC-related label Last Update Submitted that Met QC Criteria appears alongside a revision note showing v3.4.0 (with No FEAR Act Data wording adjusted). No changes were made to core study content, eligibility criteria, or outcomes.
    Difference
    0.2%
    Check dated 2026-01-27T21:31:35.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The Locations section now lists Minnesota as a study site. The Minnesota Locations entry and the HHS Vulnerability Disclosure section were removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T22:43:37.000Z thumbnail image

Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.